	Capital Social Ordinario		Fecha
AbbVie	USD 1.77B	1.75B	2025-06
Agios Pharmaceuticals	USD 58.28M	241K	2025-09
ALKERMES	USD 165.1M	49K	2025-09
Amgen	USD 538M	300K	2025-09
Biogen	USD 146.7M	200K	2025-09
BioMarin Pharmaceutical	USD 192.1M	97K	2025-09
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Eli Lilly	USD 946.83M	354.23M	2025-06
Exelixis	USD 268.1M	2.03M	2025-09
Genmab	DKK 10M	56M	2025-03
Gilead Sciences	USD 1.24B	0	2025-09
GlaxoSmithKline	GBP 4.08B	49.43M	2025-12
Glaxosmithkline	GBP 4.03B	2.68B	2025-09
Incyte	USD 196.13M	2.01M	2025-09
Ionis Pharmaceuticals	USD 161.14M	160.98M	2025-09
J&J	USD 2.41B	584K	2025-09
Merck	USD 2.49B	15.79M	2025-09
Moderna	USD 391M	2M	2025-09
Neurocrine Biosciences	USD 99.7M	700K	2025-09
Novartis	USD 1.94B	23.4M	2025-06
Novartis	USD 1.92B	17.06M	2025-09
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 79.93M	554K	2025-09
Regeneron Pharmaceuticals	USD 105.3M	1.1M	2025-09
Roche Holding	CHF 795.62M	699.54K	2025-12
Sarepta Therapeutics	USD 104.77M	7.06M	2025-09
Takeda	JPY 1.58B	2K	2025-12
Teva Pharmaceutical Industries	USD 1.15B	0	2025-12
Ultragenyx Pharmaceutical	USD 96.44M	88K	2025-09
Vertex Pharmaceuticals	USD 254M	2.29M	2025-09

Amgen Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.